✦ LIBER ✦

Development of an HSV-Based Vector for the Treatment of Parkinson's Disease

✍ Scribed by David J. Fink; P.Luigi Poliani; Thomas Oligino; David M. Krisky; William F. Goins; Joseph C. Glorioso

Book ID: 115606472
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 437 KB
Volume: 144
Category: Article
ISSN: 0014-4886
DOI: 10.1006/exnr.1996.6395

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Viral vectors in the treatment of Parkin

Viral vectors in the treatment of Parkinson's disease

✍ David S. Latchman; Robert S. Coffin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro

Treatment interventions for Parkinson's

Treatment interventions for Parkinson's disease: an evidence based assessment

✍ Olivier Rascol; Christopher Goetz; William Koller; Werner Poewe; Cristina Sampai 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 129 KB

New hope for mechanism-based treatment o

New hope for mechanism-based treatment of Parkinson's disease

✍ Jane Bradbury 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Recent developments in the pharmacologic

Recent developments in the pharmacological treatment of Parkinson’s disease

✍ Tuite, Paul; Riss, Jennifer 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 296 KB

Pramipexole in the treatment of Parkinso

Pramipexole in the treatment of Parkinson’s disease: new developments

✍ Möller, J Carsten; Oertel, Wolfgang H 📂 Article 📅 2005 🏛 Expert Reviews 🌐 English ⚖ 73 KB

Istradefylline for the treatment of Park

Istradefylline for the treatment of Parkinson's disease

✍ Park, Ariane; Stacy, Mark 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 190 KB